Always consult the doctor before use
Summary: Retatrutide is administered as a once-weekly subcutaneous injection into the abdomen, thigh, or upper arm, exclusively within regulated clinical trials, as it remains unlicensed in the UK
In summary, current evidence indicates that GLP-1RAs modulate gut microbiota in ways that may underlie their metabolic and organ-protective effects, although heterogeneity between models and trials remains
But Ozempic and Wegovy are the exact same drug, according to Brian Wojeck, assistant professor of endocrinology at the Yale School of Medicine
Are GLP-1 Medications Alone Enough to Help You
Glutathione defends the system that keeps you young